Transitional cell carcinoma
00:00 / 00:00
Videos
Notes
Transitional cell carcinoma
Renal system
Renal and ureteral disorders
Metabolic acidosis
Metabolic alkalosis
Respiratory acidosis
Respiratory alkalosis
Acute tubular necrosis
Postrenal azotemia
Prerenal azotemia
Renal azotemia
Horseshoe kidney
Potter sequence
Renal agenesis
Hypercalcemia
Hyperkalemia
Hypermagnesemia
Hypernatremia
Hyperphosphatemia
Hypocalcemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypophosphatemia
Hydronephrosis
Kidney stones
Renal cortical necrosis
Renal papillary necrosis
Alport syndrome
Goodpasture syndrome
IgA nephropathy (NORD)
Lupus nephritis
Poststreptococcal glomerulonephritis
Rapidly progressive glomerulonephritis
Amyloidosis
Diabetic nephropathy
Focal segmental glomerulosclerosis (NORD)
Lupus nephritis
Membranoproliferative glomerulonephritis
Membranous nephropathy
Minimal change disease
Acute pyelonephritis
Chronic pyelonephritis
Medullary cystic kidney disease
Medullary sponge kidney
Multicystic dysplastic kidney
Polycystic kidney disease
Chronic kidney disease
Renal tubular acidosis
Angiomyolipoma
Beckwith-Wiedemann syndrome
Nephroblastoma (Wilms tumor)
Renal cell carcinoma
WAGR syndrome
Renal artery stenosis
Renal system pathology review
Acid-base disturbances: Pathology review
Congenital renal disorders: Pathology review
Electrolyte disturbances: Pathology review
Kidney stones: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Renal and urinary tract masses: Pathology review
Renal failure: Pathology review
Renal tubular acidosis: Pathology review
Renal tubular defects: Pathology review
Urinary incontinence: Pathology review
Urinary tract infections: Pathology review
Assessments
Transitional cell carcinoma
Flashcards
0 / 13 complete
USMLE® Step 1 questions
0 / 1 complete
High Yield Notes
5 pages
Flashcards
Transitional cell carcinoma
of complete
Questions
USMLE® Step 1 style questions USMLE
of complete
Reproduced from: Wikimedia Commons
Which of the following is the most common risk factor associated with this patient's condition?
External References
First Aid
2022
2021
2020
2019
2018
2017
2016
Aniline dyes p. 624
transitional cell carcinoma and p. 624
Bladder p. 649
transitional cell carcinoma p. 624
Cyclophosphamide p. 449
transitional cell carcinoma and p. 624
Hematuria p. 620
transitional cell carcinoma p. 624
Smoking
transitional cell carcinoma p. 624
Ureter p. 603, 645, 649, 650
transitional cell carcinoma in p. 624
Transcript
Content Reviewers
Contributors
The most common form of cancer in the lower urinary tract—or the bladder and the urethra— is transitional cell carcinoma (or TCC), and to be more specific, urothelial cell carcinoma (or UCC).
While this cancer can affect tissues in the upper urinary tract, such as the renal pelvis and the ureter, it most commonly arises in the urothelium of the bladder.
The urothelium (or uroepithelium) is a specific type of transitional cell epithelium that lines the inner surface of much of the urinary tract. This tissue is composed of 3–7 cell layers, and it forms a tight barrier which holds urine without allowing toxins to move across the epithelium and back into the body.
That barrier function is largely accomplished by large umbrella cells that line the inner or luminal surface of the urothelium, and are held together by high resistance tight junctions, and are lined with a unique protein/lipid complex, called a plaque, along their apical membrane.
Now when you think about the bladder, it’s going to cyclically change shape during the course of its normal function.
For example, after you chug a tall mango lassi, your bladder will become completely filled up only to be emptied again when you rush to the restroom. Therefore, the urothelium has to be able to maintain its impermeable properties during these normal changes in bladder shape. Most of this is allowed for by the unfolding of the mucosal surface when the bladder fills up.
When the bladder is empty, this surface is highly wrinkled with rugae which then smooths out as the bladder becomes distended. In addition to this, these umbrella cells of the urothelium, have the ability to stretch with an expanding bladder. In fact, the term “transition” of transitional epithelium refers to this ability to go through transitions of shape.
Summary
Transitional cell carcinoma (TCC), also known as urothelial cell carcinoma, is a type of cancer that affects the transitional cells that line the bladder, ureters, and renal pelvis. It is the most common type of bladder cancer, and can cause symptoms such as blood in the urine, painful urination, frequent urination, and back or abdominal pain. TCC is typically treated with a combination of surgery, radiation therapy, chemotherapy, or immunotherapy, and the prognosis depends on the stage and location of the cancer, as well as the individual's overall health. Early diagnosis and treatment can improve the chances of recovery and long-term survival.
Sources
- "Robbins Basic Pathology" Elsevier (2017)
- "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
- "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
- "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
- "Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014" BMC Cancer (2016)
- "Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases" PubMed (undefined)
- "Dilemmas in the treatment of urothelial cancers of the prostate" Urologic Oncology: Seminars and Original Investigations (2009)
For Institutions
Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.
